MYCOBACTERIUM - ANVISA Registration 82890930015
Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 82890930015 and manufactured by manufacturer not specified. The registration is held by R-BIOPHARM BRASIL COMERCIO DE PRODUTOS PARA ANALISE DE ALIMENTOS LTDA with validity until Jul 07, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
82890930015
25351027423202584
67272757000296
Company Information
Dates and Status
Jul 07, 2025
07/07/2035
09/18/2025 19:00:01
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025
MYCOBACTERIUM
RIDASCREEN® TB
Not specified
82890930012
Jun 23, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
TUBERCULOSE RAPID TEST
DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA - ME
80638720172
Feb 08, 2021
MYCOBACTERIUM
RIDA® TB Tubes
R-BIOPHARM AG
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDA® TB Tubes
Not specified
82890930018
Sep 15, 2025
MYCOBACTERIUM
RIDASCREEN® TB
R-BIOPHARM AG
82890930012
Jun 23, 2025
MYCOBACTERIUM
RIDASCREEN® TB
Not specified
82890930012
Jun 23, 2025
MYCOBACTERIUM
FamĂlia AutoLumo TB-IGRA MicropartĂculas (CLIA)
Not specified
80102513450
Jun 16, 2025